Tom Steyer’s $100M bet on Natera highlights high-conviction interest in genetic testing’s growth and signals a potential breakout for the stock.
Key takeaways
- Billionaire Tom Steyer Backs Natera Inc. as a High-Growth Stock Opportunity
- Billionaire investor and former presidential candidate Tom Steyer has made a sizable bet on Natera Inc. (NASDAQ: NTRA), signaling rare, high-conviction interest in the...
- Natera specializes in cell-free DNA testing for cancer, women’s health, and organ health — a $50 billion addressable market by some Wall Street estimates. The company’...
- Steyer’s backing stands out. He’s not a sector tourist: Farallon’s bets tend to run concentrated and, historically, he’s favored high-growth disruptors on the brink of...
👉 Read the full breakdown on MLXIO
Canonical source: https://mlxio.com/finance/tom-steyer-bets-natera-genetic-testing
Top comments (0)